#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marfan's syndrome Heavy menstrual bleeding Cutaneous T-cell lymphoma stage I Palmoplantar pustulosis Severe myoclonic epilepsy of infancy Angiosarcoma Osteomyelitis Barth syndrome Mantle cell lymphoma stage III Desmoplastic small round cell tumour Cytokine release syndrome White matter lesion Acute myeloid leukaemia recurrent Immunoglobulin G4 related disease Gestational trophoblastic tumour More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma Mantle cell lymphoma stage III – Trials in Disease Marfan’s syndrome – Trials in Disease Mantle cell lymphoma stage III Marginal zone lymphoma refractory – Basic Information Haemolytic uraemic syndrome – Basic Information Kearns-Sayre syndrome – Life with Disease Metachromatic leukodystrophy – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Angelman’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Ulipristal Acetate Tradipitant Sacituzumab Tirumotecan Calcium Chloride Dihydrate Isatuximab Nizatidine LUTETIUM LU-177 Goserelin Acetate Latozinemab Choriogonadotropin Alfa 4-Hydroxy-N-Desmethyltamoxifen Dermatophagoides Pteronyssinus Golimumab Tinzaparin Sodium Tofacitinib Vismodegib Teplizumab Soticlestat Pemetrexed Disodium More therapies…

    Learn about Your Condition

    Univentricular heart Essential thrombocythaemia Labour pain Pustular psoriasis Chondrosarcoma metastatic Head and neck cancer stage III Chronic coronary syndrome B-cell lymphoma Hyperoxaluria Skin wrinkling Eczema Vitamin D deficiency Menopause Hyperglycaemia Low cardiac output syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adenocarcinoma pancreas

  • Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Adenocarcinoma pancreas
    • Non-small cell lung cancer
    Investigated Drugs:
    • 177LU-FAP-2286
    • Calcium Folinate
    • Irinotecan
    Belgium France Italy Spain

  • Evaluating 68Ga-FAPI-46 PET/CT Scanning for Improved Diagnosis in Patients with Pancreatic Cancer or Bile Duct Cancer Eligible for Curative Treatment

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Gallium (68Ga) Chloride
    • Germanium (68Ge) Chloride
    France

  • Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Levoleucovorin
    • Ciprofloxacin
    • Irinotecan
    France

  • Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • Study of TCR-Modified T Cell Therapy with ANOC-001, ANOC-002, and ANOC-003 for Adults with Advanced Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANOC-001
    Denmark Germany The Netherlands Sweden

  • Study of RR001 with Gemcitabine and Paclitaxel for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Autologous Human Adipose Perivascular Stromal Cells Genetically Modified To Secrete Soluble Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Italy
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!